Literature DB >> 30657641

Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis.

Do-Yeon Cho1,2, Daniel Skinner1, Calvin Mackey1, Harold B Lampkin1, Jeffrey Brent Elder1, Dong Jin Lim1, Shaoyan Zhang1, Justin McCormick1, Guillermo J Tearney3, Steven M Rowe2,4,5,6, Bradford A Woodworth1,2.   

Abstract

BACKGROUND: Enhancing chloride (Cl- ) secretion in sinus epithelia represents a novel therapeutic approach to chronic rhinosinusitis (CRS). Herbal dry extract BNO 1011 enhances mucociliary clearance (MCC) via upregulation of Cl- secretion in sinonasal cultures in vitro and murine epithelium in vivo. The objective of this study is to evaluate whether the BNO 1011 improves MCC and clinical parameters in a rabbit model of CRS.
METHODS: After the development of CRS in 30 New Zealand white rabbits, animals were randomly assigned to receive oral placebo (n = 10), BNO 1011 (low dose [LD], 25 mg/kg/daily) (n = 10), or BNO1011 (high dose [HD], 125 mg/kg/daily) (n = 10) for 4 weeks. Outcomes included sinus opacification (Kerschner's rabbit sinus CT grade), maxillary epithelial Cl- secretion (sinus potential difference [PD] assay), airway surface liquid (ASL) depth using micro-optical coherence tomography (μOCT), and submucosal gland density (SMD) on histopathology. Outcome parameters were analyzed by 2 blinded investigators.
RESULTS: BNO 1011 significantly cleared sinus opacification (HD = 1.21 ± 0.63, LD = 1.26 ± 0.37,) compared to placebo (4.02 ± 0.92) (p = 0.009). BNO 1011 resulted in markedly greater mean sinus PD polarization (HD = -12.23 ± 1.4 mV, LD = -12.0 ± 3.0 mV) when compared to rabbits treated with placebo (-4.1 ± 1.1 mV) (p = 0.03). ASL depth was significantly improved when treated with HD (4.08 ± 0.06 μm) and LD (4.05 ± 0.06 μm) compared to placebo (3.5 ± 0.05 μm) (post hoc analysis, p < 0.0001). Histologically, epithelial thickness (HD = 10.0 ± 0.7 μm; LD = 13.7 ± 0.9 μm; placebo = 21.1 ± 2.3 μm; p < 0.005), subepithelial thickness (HD = 63.1 ± 6.6 μm; LD = 103.2 ± 6.7 μm; placebo = 113.3 ± 6.0 μm; p < 0.001), and SMD (HD = 22.2 ± 2.9%; LD = 31.8 ± 1.1%; placebo = 43.8 ± 1.7%; p < 0.0001) were noticeably better with the HD.
CONCLUSION: Herbal dry extract BNO 1011 improves radiographic, histologic, and MCC parameters in a rabbit model of CRS.
© 2019 ARS-AAOA, LLC.

Entities:  

Keywords:  chronic rhinosinusitis; herbal dry extract; micro optical coherence tomography; mucociliary clearance; rabbit model of sinusitis; rabbit sinusitis; sinus potential difference

Mesh:

Substances:

Year:  2019        PMID: 30657641      PMCID: PMC6555666          DOI: 10.1002/alr.22290

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  45 in total

1.  Patterns of sinusitis in cystic fibrosis.

Authors:  V G Gentile; G Isaacson
Journal:  Laryngoscope       Date:  1996-08       Impact factor: 3.325

Review 2.  Mucociliary clearance in the airways.

Authors:  A Wanner; M Salathé; T G O'Riordan
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

Review 3.  Management of the upper airway in cystic fibrosis.

Authors:  Elisa A Illing; Bradford A Woodworth
Journal:  Curr Opin Pulm Med       Date:  2014-11       Impact factor: 3.155

4.  The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.

Authors:  S Vamsee Raju; Vivian Y Lin; Limbo Liu; Carmel M McNicholas; Suman Karki; Peter A Sloane; Liping Tang; Patricia L Jackson; Wei Wang; Landon Wilson; Kevin J Macon; Marina Mazur; John C Kappes; Lawrence J DeLucas; Stephen Barnes; Kevin Kirk; Guillermo J Tearney; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

Review 5.  The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Authors:  George M Solomon; Lianwu Fu; Steven M Rowe; James F Collawn
Journal:  Curr Opin Pharmacol       Date:  2017-11-10       Impact factor: 5.547

Review 6.  The pathology of chronic obstructive pulmonary disease.

Authors:  James C Hogg; Wim Timens
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

7.  A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.

Authors:  M R Knowles; K W Hohneker; Z Zhou; J C Olsen; T L Noah; P C Hu; M W Leigh; J F Engelhardt; L J Edwards; K R Jones
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

8.  Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis.

Authors:  R Jund; M Mondigler; H Steindl; H Stammer; P Stierna; C Bachert
Journal:  Rhinology       Date:  2012-12       Impact factor: 3.681

9.  Sinupret activates CFTR and TMEM16A-dependent transepithelial chloride transport and improves indicators of mucociliary clearance.

Authors:  Shaoyan Zhang; Daniel Skinner; Stephen Bradley Hicks; Mark O Bevensee; Eric J Sorscher; Ahmed Lazrak; Sadis Matalon; Carmel M McNicholas; Bradford A Woodworth
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

10.  Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis.

Authors:  Rainer Jund; Martin Mondigler; Holger Stammer; Pontus Stierna; Claus Bachert
Journal:  Acta Otolaryngol       Date:  2015-01       Impact factor: 1.494

View more
  5 in total

1.  Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.

Authors:  Dong-Jin Lim; Justin McCormick; Daniel Skinner; Shaoyan Zhang; Jeffrey B Elder; John G McLemore; Mark Allen; John Martin West; Jessica W Grayson; Steven M Rowe; Bradford A Woodworth; Do-Yeon Cho
Journal:  Int Forum Allergy Rhinol       Date:  2019-12-23       Impact factor: 3.858

2.  The impact of Lactococcus lactis (probiotic nasal rinse) co-culture on growth of patient-derived strains of Pseudomonas aeruginosa.

Authors:  Do-Yeon Cho; Daniel Skinner; Dong Jin Lim; John G Mclemore; Connor G Koch; Shaoyan Zhang; William E Swords; Ryan Hunter; David K Crossman; Michael R Crowley; Jessica W Grayson; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2020-01-10       Impact factor: 3.858

3.  In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms.

Authors:  Dong-Jin Lim; Daniel Skinner; John Mclemore; Nick Rivers; Jeffrey Brent Elder; Mark Allen; Connor Koch; John West; Shaoyan Zhang; Harrison M Thompson; Justin P McCormick; Jessica W Grayson; Do-Yeon Cho; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-11-06       Impact factor: 3.858

4.  Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia.

Authors:  Do-Yeon Cho; Shaoyan Zhang; Daniel F Skinner; Dong Jin Lim; Catherine Banks; Jessica W Grayson; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2021-10-26       Impact factor: 5.426

Review 5.  Antibiotic eluting sinus stents.

Authors:  Harrison M Thompson; Dong-Jin Lim; Catherine Banks; Jessica W Grayson; Samrath Ayinala; Do-Yeon Cho; Bradford A Woodworth
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.